Antitumor and antimetastatic effects of interleukin 12

Cancer Chemotherapy and Pharmacology, Supplement

Volumn 38, Issue , 1996, Pages

  Fujiwara, Hiromi ^a   Hamaoka, Toshiyuki ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Antimetastatic effect; Antirumor effect; Interferon (IFN ); Interleukin 12 (IL 12)

Indexed keywords

ANTIMETASTATIC AGENT; GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 12;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FIBROSARCOMA; IMMUNOHISTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL;

EID: 0029814589     PISSN: 09439404     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800051032     Document Type: Conference Paper

References (20)

1. Brunda MJ (1994) Interleukin-12. J Leukocyte Biol 55: 280
2. Brunda MJ, Luistro L, Warrier RR, Wright RB, Hubbard BR, Murphy M, Wolf SF, Gately MK (1993) Antitumor and antimetastatic activity of interleukin-12 against murine tumors. J Exp Med 178: 1223
3. Brunda MJ, Luistro L, Hendrzak JA, Fountoulakis M, Garotta G, Gately MK (1995) Role of interferon-γ in mediating the antitumor efficacy of interleukin-12. J Immunotner 17: 71
4. Fujiwara H, Hamaoka T (1995) Regulatory mechanisms of antitumor immune responses in the tumor-bearing state. Immunol Res 14: 271
5. Fujiwara H, Hamaoka T (1995) A sequence of cellular and molecular events involved in IL-12-induced tumor regression. Res Immunol 146: 638
6. Fujiwara H, Clark SC, Hamaoka T (1996) Cellular and molecular mechanisms underlying IL-12-induced tumor regression (conference on interleukin 12). Ann NY Acad Sci (in press)
7. Hashimoto M, Niwa O, Nitta Y, Takeichi M, Yokoro K (1989) Unstable expression of E-cadherin adhesion molecules in metastatic ovarian tumor cells. Jpn J Cancer Res 80: 459
8. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, Loudon R, Sherman F, Perussia B, Trinchieri G (1989) Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes. J Exp Med 170: 827
9. + T-cell function. Jpn J Cancer Res 84: 315
10. Mu J, Zou JP, Yamamoto N, Tsutsui T, Tai XG, Kobayashi M, Herrmann S, Fujiwara H, Hamaoka T (1995) Administration of rIL-12 prevents outgrowth of tumor cells metastasizing spontaneously to lung and lymph nodes. Cancer Res 55: 4404
11. Nastala CL, Edington HD, McKinney TG, Tahara H, Nalesnik MA, Brunda MJ, Gately MK, Wolf SF, Schreiber RD, Stewart WT, Storkus J, Lotze MT (1994) Recombinant interleukin-12 (IL-12) administration induces tumor regression in association with interferon-γ production. J Immunol 153: 1697
12. Noguchi Y, Richards EC, Chen YT, Old LJ (1995) Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma. Proc Natl Acad Sci USA 92: 2219
13. Ogata M, Shimizu J, Kosaka H, Maekawa R, Shimizu K, Fujiwara H, Hamaoka T (1986) Expression of H-2 antigens and inducibility of anti-tumor immune responses in various tumor cell clones established from methylcholanthrene-induced fibrosarcoma. Jpn J Cancer Res 77: 1134
14. Stern AS, Podlaski FJ, Hulmes JD, Pan YE, Quinn PM, Wolitzky AG, Familletti PC, Stremlo DL, Truitt T, Chizzonite R, Gately MK (1990) Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc Natl Acad Sci USA 87: 6806
15. Tada T, Ohzeki S, Utsumi K, Takiuchi H, Muramatsu M, Li XF, Shimizu J, Fujiwara H, Hamaoka T (1991) Transforming growth factor-β-induced inhibition of T-cell function: susceptibility difference in T-cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state. J Immunol 146: 1077
16. Trinchieri G (1993) Interleukin-12 and its role in the generation of THl cells. Immunol Today 14: 335
17. Verbik DJ, Stinson WW, Brunda MJ, Kessinger A, Joshi SS (1995) Therapeutic effects of in vivo administration of interleukin-12 against residual lymphoma. Proc Am Assoc Cancer Res 36: 480
18. Yamamoto N, Zou JP, Li XF, Takenaka H, Noda S, Fujii T, Ono S, Kobayashi Y, Mukaida N, Matsushima K, Fujiwara H, Hamaoka T (1995) Regulatory mechanisms for production of IFN-γ and TNF by anti-tumor T cells or macrophages in the tumor-bearing state. J Immunol 154: 2281
19. Yu W-G, Yamamoto N, Takenaka H, Mu J, Tai X-G, Zou J-P, Qgawa M, Tsutsui T, Wijesuriya, Yoshida R, Herrmann S, Fujiwara H, Hamaoka T (1996) Molecular mechanisms underlying IFN-y-mediated tumor growth inhibition induced during tumor immunotherapy with rIL-12. Int Immunol (in press)
20. Zou JP, Yamamoto N, Fujii T, Takenaka H, Kobayashi M, Herrmann SH, Wolf SF, Fujiwara H, Hamaoka T (1995) Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed interferon-γ production by anti-tumor T-cells. Int Immunol 7: 1135